Icecure Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Icecure Medical
ICCM Stock  USD 0.68  0.02  3.03%   
Icecure Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Icecure Medical's valuation are provided below:
Gross Profit
1 M
Market Capitalization
45.4 M
Enterprise Value Revenue
11.9822
Revenue
3 M
Earnings Share
(0.25)
There are over one hundred nineteen available fundamental trends for Icecure Medical, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to confirm Icecure Medical's regular fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 15th of January 2026, Market Cap is likely to grow to about 60.5 M. Also, Enterprise Value is likely to grow to about 59.2 M

Icecure Medical Total Revenue

2.21 Million

Check Icecure Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Icecure Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 400.9 K, Interest Expense of 164.3 K or Selling General Administrative of 10.8 M, as well as many indicators such as Price To Sales Ratio of 18.58, Dividend Yield of 0.0 or PTB Ratio of 7.66. Icecure financial statements analysis is a perfect complement when working with Icecure Medical Valuation or Volatility modules.
  
Build AI portfolio with Icecure Stock
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

Icecure Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding61.4 M58.5 M20.3 M
Slightly volatile
Total Assets12.8 M14.5 M9.9 M
Slightly volatile
Other Current Liabilities2 M3.9 M1.7 M
Slightly volatile
Total Current Liabilities6.7 M6.3 M2.7 M
Slightly volatile
Property Plant And Equipment Net2.1 M2 M819.2 K
Slightly volatile
Accounts Payable1.5 M1.4 M515.6 K
Slightly volatile
Cash9.2 M8.7 M7.1 M
Slightly volatile
Non Current Assets Total2.2 M2.1 M874.9 K
Slightly volatile
Non Currrent Assets Other66.2 K52.9 K55.2 K
Pretty Stable
Cash And Short Term Investments9.3 M8.7 M7.1 M
Slightly volatile
Net Receivables194.2 K254.2 K140.6 K
Slightly volatile
Liabilities And Stockholders Equity12.8 M14.5 M9.9 M
Slightly volatile
Non Current Liabilities Total137.7 K144.9 K673.5 K
Pretty Stable
Inventory1.3 M2.3 M1 M
Slightly volatile
Other Current Assets1.1 M1.1 M800.7 K
Slightly volatile
Other Stockholder Equity68.3 M129.1 M58.2 M
Slightly volatile
Total Liabilities3.8 M6.5 M3.2 M
Slightly volatile
Total Current Assets11.8 M12.4 M9.1 M
Slightly volatile
Common Stock6.1 M5.8 M2.8 M
Slightly volatile
Short and Long Term Debt Total462.5 K413.1 K689.5 K
Slightly volatile
Other Liabilities528.4 K556.2 K1.9 M
Slightly volatile
Net Invested Capital15.2 M7.9 M8.8 M
Slightly volatile
Short and Long Term Debt2.6 M2.9 M3.2 M
Slightly volatile
Non Current Liabilities Other528.4 K556.2 K1.6 M
Slightly volatile
Net Working Capital5.7 M6 M7.7 M
Slightly volatile
Short Term Debt285.1 K536.4 K588.5 K
Slightly volatile
Property Plant Equipment1.4 M2.3 M951.7 K
Slightly volatile
Capital Lease Obligations584.1 K413.1 K765.8 K
Slightly volatile
Property Plant And Equipment Gross2.3 M3.8 M1.4 M
Slightly volatile
Accumulated Other Comprehensive Income2.7 M3.1 M2.5 M
Slightly volatile

Icecure Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization400.9 K381.8 K169.3 K
Slightly volatile
Interest Expense164.3 K215.1 K251.3 K
Slightly volatile
Selling General Administrative10.8 M10.2 M3.4 M
Slightly volatile
Selling And Marketing Expenses1.8 M1.3 M1.6 M
Pretty Stable
Total Revenue2.2 M3.8 M1.8 M
Slightly volatile
Other Operating Expenses22.9 M21.8 M9.9 M
Slightly volatile
Research Development4.1 M8.2 M3.5 M
Slightly volatile
Cost Of Revenue1.2 M2.1 M1 M
Slightly volatile
Total Operating Expenses20.7 M19.7 M8.8 M
Slightly volatile
Reconciled Depreciation365.2 K381.8 K247.9 K
Slightly volatile

Icecure Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation576.3 K999.4 K484.3 K
Slightly volatile
Begin Period Cash Flow8.4 M12.1 M6.9 M
Slightly volatile
Depreciation400.9 K381.8 K169.3 K
Slightly volatile
Capital Expenditures77.6 K81.7 K172.9 K
Slightly volatile
Total Cash From Financing Activities7.8 M10.6 M7.5 M
Pretty Stable
End Period Cash Flow9 M8.7 M7.8 M
Slightly volatile
Change To Netincome274.5 K288.9 K628.3 K
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio18.5819.5641.5901
Very volatile
Days Sales Outstanding20.7922.0619.3356
Slightly volatile
Average Payables276.8 K481.8 K307.4 K
Slightly volatile
Stock Based Compensation To Revenue0.310.30.2922
Pretty Stable
Capex To Depreciation0.180.191.1593
Pretty Stable
EV To Sales16.2217.0737.1299
Very volatile
Inventory Turnover1.391.061.5205
Slightly volatile
Days Of Inventory On Hand265355287
Slightly volatile
Payables Turnover3.341.723.5355
Slightly volatile
Sales General And Administrative To Revenue1.683.111.9385
Slightly volatile
Average Inventory1.5 M1.4 M815.3 K
Slightly volatile
Research And Ddevelopement To Revenue1.541.941.9831
Pretty Stable
Capex To Revenue0.01840.01940.1094
Slightly volatile
Cash Per Share0.160.170.8931
Slightly volatile
Days Payables Outstanding116220129
Slightly volatile
Income Quality0.680.740.8206
Very volatile
Net Debt To EBITDA0.820.420.8914
Pretty Stable
Current Ratio2.132.243.9601
Pretty Stable
Receivables Turnover16.2717.13154.9 K
Slightly volatile
Capex Per Share0.00150.00160.0409
Slightly volatile
Revenue Per Share0.07070.07440.2694
Slightly volatile
Interest Debt Per Share0.00990.01040.1697
Slightly volatile
Debt To Assets0.03990.0420.2457
Slightly volatile
Operating Cycle286377306
Slightly volatile
Days Of Payables Outstanding116220129
Slightly volatile
Ebt Per Ebit1.171.121.0993
Slightly volatile
Total Debt To Capitalization0.06810.07170.6802
Slightly volatile
Quick Ratio1.741.833.5434
Pretty Stable
Net Income Per E B T0.810.910.9864
Slightly volatile
Cash Ratio1.51.583.2241
Slightly volatile
Cash Conversion Cycle170157177
Slightly volatile
Days Of Inventory Outstanding265355287
Slightly volatile
Days Of Sales Outstanding20.7922.0619.3356
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.911.0082
Slightly volatile
Fixed Asset Turnover2.022.136.0353
Slightly volatile
Debt Ratio0.03990.0420.2457
Slightly volatile
Price Sales Ratio18.5819.5641.5901
Very volatile
Asset Turnover0.250.30.2575
Slightly volatile

Icecure Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.5 M50.4 M61.1 M
Slightly volatile
Enterprise Value59.2 M44 M56.6 M
Slightly volatile

Icecure Fundamental Market Drivers

Icecure Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Icecure Medical Financial Statements

Icecure Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Icecure Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue384.1 K450.7 K
Total Revenue3.8 M2.2 M
Cost Of Revenue2.1 M1.2 M
Stock Based Compensation To Revenue 0.30  0.31 
Sales General And Administrative To Revenue 3.11  1.68 
Research And Ddevelopement To Revenue 1.94  1.54 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.07  0.07 
Ebit Per Revenue(4.29)(4.51)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
How To Invest In Icecure
Details
Is Icecure Stock a good investment?
Details
What is Icecure Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.25)
Revenue Per Share
0.05
Quarterly Revenue Growth
0.284
Return On Assets
(0.63)
Return On Equity
(1.58)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY